Physician profile
Peter Neff
NPI 1760809966
$51,728.93
in general payments reported to CMS, 2019-2025
20 companies · $691 in 2025
The $691 reported for 2025 was more than what 86% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $9,143 · 2021: $8,725 · 2022: $4,206 · 2023: $81.46 · 2024: $132 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481 · Travel and Lodging: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.61 |
| Travel and Lodging | $423.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,724.81 | 2019-2022 | |
| Medinc of Texas | $7,595.31 | 2020-2024 | |
| Gemini Mountain Medical, LLC | $5,983.57 | 2019 | |
| Djo, LLC | $5,624.99 | 2019-2021 | |
| Smith+Nephew, INC. | $4,669.92 | 2020-2023 | Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $2,363.28 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $1,670.85 | 2022-2025 | Comprehensive Shoulder System |
| Mission Medical Distribution, LLC | $423.89 | 2025 | |
| Fx Shoulder Solutions, INC | $150.99 | 2020 | |
| Onkos Surgical, INC. | $105.65 | 2019 | |
| Medacta USA, INC. | $93.46 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $82.64 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $70.92 | 2022-2025 | Exparel, Iovera, Zilretta |
| Innovation Technologies INC | $49.63 | 2024 | Irrisept |
| Heron Therapeutics, INC. | $28.03 | 2025 | Zynrelef |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $25.79 | 2025 | Versawrap |
| Convatec INC. | $20.30 | 2025 | |
| Depuy Synthes Sales INC. | $19.04 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.03 | 2023 | Seglentis |
| Bioventus LLC | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Neff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.